174 related articles for article (PubMed ID: 24399074)
1. Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14.
Ding X; Xiang L; Wang N; Zhao Z; Jin X; Sun Y; Duan W; Wang S; Jin X
Oncol Rep; 2014 Mar; 31(3):1165-74. PubMed ID: 24399074
[TBL] [Abstract][Full Text] [Related]
2. Vandetanib inhibits cisplatin‑resistant neuroblastoma tumor growth and invasion.
Li C; Yang C; Wei G
Oncol Rep; 2018 Apr; 39(4):1757-1764. PubMed ID: 29436676
[TBL] [Abstract][Full Text] [Related]
3. SOX17 inhibits proliferation and invasion of neuroblastoma through CXCL12/CXCR4 signaling axis.
Wang XH; Zhang SF; Wu HY; Gao J; Wang XH; Gao TH
Cell Signal; 2021 Nov; 87():110093. PubMed ID: 34302955
[TBL] [Abstract][Full Text] [Related]
4. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
Liu Y; Ren CC; Yang L; Xu YM; Chen YN
J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
[TBL] [Abstract][Full Text] [Related]
5. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.
Li JK; Yu L; Shen Y; Zhou LS; Wang YC; Zhang JH
World J Gastroenterol; 2008 Apr; 14(15):2308-13. PubMed ID: 18416455
[TBL] [Abstract][Full Text] [Related]
9. Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.
Ferrari SM; Bocci G; Di Desidero T; Ruffilli I; Elia G; Ragusa F; Fioravanti A; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P
Oncol Rep; 2018 May; 39(5):2306-2314. PubMed ID: 29517106
[TBL] [Abstract][Full Text] [Related]
10. Isatin inhibits the proliferation and invasion of SH-SY5Y neuroblastoma cells.
Xu P; Hou L; Ju C; Zhang Z; Sun W; Zhang L; Song J; Lv Y; Liu L; Chen Z; Wang Y
Mol Med Rep; 2016 Mar; 13(3):2757-62. PubMed ID: 26846278
[TBL] [Abstract][Full Text] [Related]
11. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4.
Manu KA; Shanmugam MK; Rajendran P; Li F; Ramachandran L; Hay HS; Kannaiyan R; Swamy SN; Vali S; Kapoor S; Ramesh B; Bist P; Koay ES; Lim LH; Ahn KS; Kumar AP; Sethi G
Mol Cancer; 2011 Sep; 10():107. PubMed ID: 21880153
[TBL] [Abstract][Full Text] [Related]
15. A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid.
Zage PE; Zeng L; Palla S; Fang W; Nilsson MB; Heymach JV; Zweidler-McKay PA
Cancer; 2010 May; 116(10):2465-75. PubMed ID: 20225331
[TBL] [Abstract][Full Text] [Related]
16. Curcumin exhibits anti-tumor effect and attenuates cellular migration via Slit-2 mediated down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma cells.
Sirohi VK; Popli P; Sankhwar P; Kaushal JB; Gupta K; Manohar M; Dwivedi A
J Nutr Biochem; 2017 Jun; 44():60-70. PubMed ID: 28402926
[TBL] [Abstract][Full Text] [Related]
17. Investigation of anticancer mechanism of oleuropein via cell cycle and apoptotic pathways in SH-SY5Y neuroblastoma cells.
Seçme M; Eroğlu C; Dodurga Y; Bağcı G
Gene; 2016 Jul; 585(1):93-99. PubMed ID: 27032461
[TBL] [Abstract][Full Text] [Related]
18. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
19. miR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4α.
Li Z; Chen H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3072-3078. PubMed ID: 31343368
[No Abstract] [Full Text] [Related]
20. MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
Zhang H; Pu J; Qi T; Qi M; Yang C; Li S; Huang K; Zheng L; Tong Q
Oncogene; 2014 Jan; 33(3):387-97. PubMed ID: 23222716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
